SNCAIP anticorps (C-Term)

N° du produit ABIN359008

Détail du produit anti-SNCAIP anticorps

Antigène: SNCAIP (Synuclein, alpha Interacting Protein (SNCAIP))

Épitope: C-Term

Reactivité: Humain, Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp SNCAIP est non-conjugé

Application: Western Blotting (WB), Enzyme Immunoassay (EIA)

Specificité: This antibody reacts to Synphilin-1 (SNCAIP).

Purification: Prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS

Immunogène: This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide in the C-terminal region of human Synphilin-1.

Isotype: Ig Fraction

Information d'application

Indications d'application: ELISA: 1/1,000. Western blotting: 1/50 - 1/100.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.25 mg/mL

Buffer: PBS with 0.09 % (W/V) sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freezing and thawing.

Stock: 4 °C/-20 °C

Stockage commentaire: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at-20 °C for longer.

Détails sur SNCAIP

Antigène: SNCAIP (Synuclein, alpha Interacting Protein (SNCAIP))

Autre désignation: Synphilin 1 / SNCAIP (SNCAIP Produits)

Synonymes: anticorps sncaip, anticorps MGC88953, anticorps SNCAIP, anticorps LOC100221074, anticorps SYPH1, anticorps Sph1, anticorps Syph1, anticorps 2810407O15Rik, anticorps 4933427B05Rik, anticorps BB104594, anticorps synuclein alpha interacting protein, anticorps synuclein, alpha interacting protein, anticorps synuclein, alpha interacting protein (synphilin), anticorps SNCAIP, anticorps sncaip, anticorps Sncaip

Sujet: Parkinson is the second most common neurodegenerative disease after Alzheimers. About 1 percent of people over the age of 65 and 3 percent of people over the age of 75 are affected by the disease. The mutation is the most common cause of Parkinson disease identified to date. Synuclein alpha interacting protein (Synphilin-1) contains several protein-protein interaction domains and interacts with alpha synuclein in neurons. Mutations of SNCAIP have been linked to Parkinson disease. The amino acid sequence of synphilin-1 shows extensive homology with its human counterpart, especially in regions containing ankyrin-like motifs and the coiled-coil domain. Expression of mouse synphilin-1 in tissues is similar to its human counterpart. Synphilin-1 has an important role in the formation of aggregates and cytotoxicity in Parkinson disease and that Dorfin may be involved in the pathogenic process by ubiquitylation of synphilin-1. Role of synphilin-1 in synaptic function and protein degradation and in the molecular mechanisms leading to neurodegeneration in Parkinson diseaseSynonyms: Alpha-synuclein-interacting protein, Sph1, Synphilin-1

ID gène: 9627

NCBI Accession: NP_005451

UniProt: Q9Y6H5